231
Participants
Start Date
October 31, 2002
Primary Completion Date
April 30, 2003
Study Completion Date
April 30, 2003
talnetant
risperidone
GSK Clinical Trial Call Center, Hollis
GSK Clinical Trial Call Center, Washington D.C.
GSK Clinical Trial Call Center, Butner
GSK Clinical Trial Call Center, Raleigh
GSK Clinical Trial Call Center, Winter Park
GSK Clinical Trial Call Center, North Miami
GSK Clinical Trial Call Center, Tampa
GSK Clinical Trial Call Center, Nashville
GSK Clinical Trial Call Center, Cleveland
GSK Clinical Trial Call Center, Cincinnati
GSK Clinical Trial Call Center, Greenwood
GSK Clinical Trial Call Center, Hoffman Estates
GSK Clinical Trial Call Center, Shreveport
GSK Clinical Trial Call Center, Norman
GSK Clinical Trial Call Center, Oklahoma City
GSK Clinical Trial Call Center, Terrell
GSK Clinical Trial Call Center, Bellaire
GSK Clinical Trial Call Center, Austin
GSK Clinical Trial Call Center, Scottsdale
GSK Clinical Trial Call Center, Pico Rivera
GSK Clinical Trial Call Center, Cerritos
GSK Clinical Trial Call Center, Rosemead
GSK Clinical Trial Call Center, Chula Vista
GSK Clinical Trial Call Center, San Diego
GSK Clinical Trial Call Center, San Diego
GSK Clinical Trial Call Center, Garden Grove
GSK Clinical Trial Call Center, Orange
GSK Clinical Trial Call Center, Sacramento
GSK Clinical Trial Call Center, New Britain
GSK Clinical Trial Call Center, New Haven
GSK Clinical Trial Call Center, Clementon
Lead Sponsor
GlaxoSmithKline
INDUSTRY